Cassandra Callender ’ s cancer is progressing, and the quackery didn ’ t stop it. Let ’ s hope real medicine can.

Cassandra Callender made national news a couple of years ago when at age 17 she was diagnosed with Hodgkin's lymphoma and refused chemotherapy. The court ordered that she undergo appropriate treatment, but unfortunately she relapsed and chose treatment at a quack clinic in Mexico. Continuing to progress, she finally chose real medicine to treat her cancer. Let's hope that it's not too late to save her.
Source: Respectful Insolence - Category: Surgery Authors: Tags: Cancer Complementary and alternative medicine Homeopathy Pseudoscience Quackery Skepticism/critical thinking AARSOTA Autologous Antigen Receptor Specific Oncogenic Target Acquisition cannabis Cassandra Callender coffee enema Hodgkin' Source Type: blogs

Related Links:

CONCLUSIONS IQGAP3 may be a potential target gene for Kaempferol in the treatment of BC, and upregulation of IQGAP3 inhibits Kaempferol-induced apoptosis in BC cells by ERK1/2 signaling activation. Targeting IQGAP3 may contribute to the study of natural phytochemicals as anti-tumor drugs in BC. PMID: 31605603 [PubMed - in process]
Source: Medical Science Monitor - Category: Research Tags: Med Sci Monit Source Type: research
Authors: Sun HB, Xu L, Wang ZX, Zheng Y, Zhao Y, Yin YY, Han XL, Xu ZN Abstract OBJECTIVE: To explore the influence of polyoxometalate SbW9 on proliferation and apoptosis of non-small cell lung cancer (NSCLC) cells and its mechanism. MATERIALS AND METHODS: NSCLC cell lines A549 and PC9 were treated with 50 μM polyoxometalate. Then, the proliferation of NSCLC cells was detected via 2,3-bis(2-methoxy-4-nitro-5-sulfophenyl)-5-[(phenylamino)carbonyl]-2H-t tetrazolium hydroxide (XTT) assay and colony formation assay; the apoptosis of NSCLC cells was detected via flow cytometry and terminal deoxynucleotidyl transf...
Source: European Review for Medical and Pharmacological Sciences - Category: Drugs & Pharmacology Tags: Eur Rev Med Pharmacol Sci Source Type: research
EXCLUSIVE: Grace Pritchard, now 20, of Worcestershire, was only diagnosed with Hodgkin's lymphoma last October when she visited her GP about breathing difficulties.
Source: the Mail online | Health - Category: Consumer Health News Source Type: news
Newly-released data is putting Grail back in the forefront of the liquid biopsy conversation. The Menlo Park, CA-based company announced data validating the performance of its investigational multi-cancer early detection blood test for the first time in an independent cohort of participants. The validation data is coming from both the Circulating Cell-Free Genome Atlas (CCGA) study. Data show Grail’s liquid biopsy test was shown to detect more than 20 cancer types across all stages with a single, very low false-positive rate. Grail will present the results at an American Society of Clinical Oncology Break...
Source: MDDI - Category: Medical Devices Authors: Tags: IVD Source Type: news
Anaplastic lymphoma kinase fusion gene-positive (ALK+) disease occurs in approximately 5% of patients with advanced non-small-cell lung cancer (NSCLC) [1]. Current standard first-line therapy for patients with advanced stage ALK+ NSCLC is an ALK inhibitor, such as crizotinib, ceritinib, brigatinib, or alectinib [2].
Source: Lung Cancer - Category: Cancer & Oncology Authors: Source Type: research
Int J Angiol DOI: 10.1055/s-0039-1697921Doxorubicin is a standard treatment option for breast cancer, lymphoma, and leukemia, but its benefits are limited by its potential for cardiotoxicity. The primary objective of this study was to compare cardiac magnetic resonance imaging (CMRI) versus echocardiography (ECHO) to detect a reduction in left ventricular ejection function, suggestive of doxorubicin cardiotoxicity. We studied eligible patients who were 18 years or older, who had breast cancer or lymphoma, and who were offered treatment with doxorubicin with curative intent dosing of 240 to 300 mg/m2 body surface are...
Source: International Journal of Angiology - Category: Cardiology Authors: Tags: Rapid Communication Source Type: research
Ilavarasi Vanidassane, Ajay Gogia, Saumyaranjan MallickIndian Journal of Cancer 2019 56(4):373-374
Source: Indian Journal of Cancer - Category: Cancer & Oncology Authors: Source Type: research
Conclusion: The incidence of bleomycin induced pulmonary toxicity and mortality was significantly higher in our study compared to that of other Western studies. This could be probably due to the increased susceptibility of the Indian patients to bleomycin induced lung damage. In a highly curable cancer such as HL, it is unacceptable to have such a high life-threating toxicity. Hence, an alternative chemotherapy regimen without bleomycin is to be explored which would prevent toxicity and hence the compromise on survival.
Source: Indian Journal of Palliative Care - Category: Palliative Care Authors: Source Type: research
This study expands on earlier reports on the therapeutic potential of distinctive tumor antigen–targeting mAbs and facilitates the understanding of the mechanism and potential of ADCC by γδ T-cell subsets.
Source: Journal of Immunotherapy - Category: Allergy & Immunology Tags: Basic Studies Source Type: research
The phosphoinositol 3-kinase (PI3K) pathway is associated with poor prognosis of hematologic malignancies, providing a strong rationale for the use of PI3K inhibitors in the treatment of malignant lymphoma. Ho...
Source: BMC Cancer - Category: Cancer & Oncology Authors: Tags: Research article Source Type: research
More News: Alternative and Complementary Therapies | Cancer | Cancer & Oncology | Chemotherapy | Complementary Medicine | Homeopathy | Legislation | Lymphoma | Mergers and Aquisitions | Surgery